Elevage Medical Technologies is a venture capital firm dedicated to supporting growth-stage medical technology companies, including devices, tools, diagnostics, and tech-enabled services, by providing capital investment and strategic operational support to advance approval and commercialization. It was formed in 2023 with backing from Patient Square Capital.
60% of their portfolio is in Healthcare. Average disclosed round size is $66.0M (across 14 rounds with reported amounts).
Portfolio
11
Fund Size
$350M
Top Stage
Series C
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nervonik | Series B | $52.5M | Apr 2026 |
| NNuclera Ltd | Series C | $87M | Jan 2026 |
 Biobeat | Series B | $50M | Dec 2025 |
 Galvanize | Bridge | — | Sep 2025 |
 Galvanize Therapeutics | Series C | $100M | Sep 2025 |
 FIRE1 | Unknown | $120M | Jan 2025 |
| NNuclera Ltd | Series A | $75M | Oct 2024 |
 Elucid | Series C | $80M | Nov 2023 |
| FIRE1 | Unknown | $25M | Mar 2023 |
 SetPoint Medical | Series D | $64M | Jan 2021 |
| SetPoint Medical | Series C | $25M | Sep 2015 |
| 44basebio | Unknown | $51M | — |
 Imperative Care | Bridge | $100M | — |
 Moximed | Growth | $40M | — |
| Elucid | Series D | $55M | — |
Top Co-Investors
Ally Bridge Group6 shared
New Enterprise Associates5 shared
Norwest Venture Partners4 shared
Gilde Healthcare3 shared
Gilmartin Capital3 shared
Morgenthaler Ventures3 shared
Sand Hill Angels2 shared
British Business Bank2 shared
Andera Partners2 shared
Longitude Capital2 shared
Seventure Partners2 shared
Lightstone Ventures2 shared
Medtronic2 shared
Sands Capital2 shared
Polaris Partners2 shared
Gimv2 shared
Novo Capital2 shared
Catalio Capital Management2 shared
Perceptive Advisors2 shared
Last updated: 20 October 2026